Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Antiviral Therapy|August 20, 2003
Comparison of nine resistance interpretation systems for HIV-1 genotypingMartin Stürmer, Hans Wilhelm Doerr, Schlomo Staszewski, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 7, 2002
Evaluation of the LiPA HIV-1 RT assay version 1: comparison of sequence and hybridization based genotyping systemsMartin Stürmer, Birgit Morgenstern, Schlomo Staszewski, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 18, 2005
HBV reactivation after kidney transplantationAnnemarie Berger, Wolfgang Preiser, Hans Georg Kachel, et al.Antimicrobial Agents and Chemotherapy|December 25, 2002
Correlation of phenotypic zidovudine resistance with mutational patterns in the reverse transcriptase of human immunodeficiency virus type 1: interpretation of established mutations and characterization of new polymorphisms at codons 208, 211, and 214Martin Stürmer, Schlomo Staszewski, Hans-Wilhelm Doerr, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 7, 2002
Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor test (manual specimen preparation)Annemarie Berger, Lina Scherzed, Martin Stürmer, et al.Journal of Virological Methods|August 24, 2010
Detection and quantitation of HBV DNA in miniaturized samples: multi centre study to evaluate the performance of the COBAS ® AmpliPrep/COBAS ® TaqMan ® hepatitis B virus (HBV) test v2.0 by the use of plasma or serum specimensAnnemarie Berger, Peter Gohl, Martin Stürmer, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 31, 2005
Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samplesAnnemarie Berger, Lina Scherzed, Martin Stürmer, et al.Antiviral Therapy|February 5, 2008
Predictive factors for response to a boosted dual HIV-protease inhibitor therapy with saquinavir and lopinavir in extensively pre-treated patientsNils von Hentig, Errol Babacan, Schlomo Staszewski, et al.Antimicrobial Agents and Chemotherapy|April 16, 2008
Decrease of atazanavir and lopinavir plasma concentrations in a boosted double human immunodeficiency virus protease inhibitor salvage regimenNils von Hentig, Pavel Kaykhin, Christoph Stephan, et al.Medical Microbiology and Immunology|January 10, 2016
Prevalence of K65R in patients treated with tenofovir disoproxil fumarate: recommendations based on the Frankfurt HIV Cohort Study Resistance Database (FHCS-RD)Claudia Reinheimer, Anna Wesner, Oliver T Keppler, et al.Pageof 4